Understanding this relationship helps clinicians counsel patients appropriately and distinguish between expected medication effects and symptoms requiring further investigation
The increasing incidence of obesity is anticipated to serve as a catalyst for the expansion of the market for glucagon-like peptide (GLP)-1 agonist medications designed for weight reduction in the upcoming period
Whey or plant-based protein powder (20-30g per serving) makes reaching your daily protein target much easier, especially when solid food feels unappealing
Patients may require ongoing supportive care and monitoring during this extended period until the medication is cleared from the body
The clinician must review the specific medications, dosing, treatment response, side effects, and relevant health conditions
With weight loss medications becoming more mainstream, it can feel overwhelming to figure out which option might be right for you